GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Beta

Surgical Innovations Group (LSE:SUN) Beta : -0.53 (As of Dec. 13, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-12-13), Surgical Innovations Group's Beta is -0.53.


Surgical Innovations Group Beta Historical Data

The historical data trend for Surgical Innovations Group's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group Beta Chart

Surgical Innovations Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.69 - - -0.21

Surgical Innovations Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.21 -0.93

Competitive Comparison of Surgical Innovations Group's Beta

For the Medical Devices subindustry, Surgical Innovations Group's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Beta distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's Beta falls into.



Surgical Innovations Group Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Surgical Innovations Group  (LSE:SUN) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Surgical Innovations Group Beta Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and equipment for precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment which derives key revenue, includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The Distribution segment includes the distribution of specialist medical products.